Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-10-31
pubmed:abstractText
Platelets activated by alpha-thrombin express surface procoagulant activity (PCA) that accelerates the conversion of prothrombin to alpha-thrombin. Following activation with 10 nM alpha-thrombin, the PCA of normal platelets was approximately five-fold higher than that of Bernard-Soulier platelets (lacking GPIb). Normal platelet PCA was inhibited approximately 50% by activation in the presence of the anti-GPIb MoAbs LJIb10 or TM60. Moreover, normal platelet PCA was completely abrogated in the presence of a combination of both LJIb10 and c7E3, a MoAb directed against alphaIIbbeta3 (GPIIb/IIIa). In contrast. PCA expressed by Bernard Soulier or Glanzmann platelets was not inhibited by either LJIb10 or c7E3 MoAb. The platelet activating peptide SFLLRN at 10 microM, a concentration which fully activates platelet aggregation and Ca2+ mobilization, generated PCA activity one fifth of that generated by alpha-thrombin at 10 nM but anti-PAR1 antibodies did not affect thrombin-induced PCA expression. These results demonstrate that GPIb mediates, at least in part, the thrombin-induced activation of platelets that leads to PCA, and that alphaIIbbeta3 is also involved in PCA generation, but these results do not support a major role for PAR1 in this activation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0340-6245
pubmed:author
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1065-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11686325-Adult, pubmed-meshheading:11686325-Bernard-Soulier Syndrome, pubmed-meshheading:11686325-Blood Coagulation Factors, pubmed-meshheading:11686325-Blood Platelets, pubmed-meshheading:11686325-Calcium Signaling, pubmed-meshheading:11686325-Female, pubmed-meshheading:11686325-Gene Expression Regulation, pubmed-meshheading:11686325-Humans, pubmed-meshheading:11686325-Male, pubmed-meshheading:11686325-Peptide Fragments, pubmed-meshheading:11686325-Platelet Activation, pubmed-meshheading:11686325-Platelet Glycoprotein GPIIb-IIIa Complex, pubmed-meshheading:11686325-Platelet Glycoprotein GPIb-IX Complex, pubmed-meshheading:11686325-Receptor, PAR-1, pubmed-meshheading:11686325-Receptors, Thrombin, pubmed-meshheading:11686325-Thrombasthenia, pubmed-meshheading:11686325-Thrombin, pubmed-meshheading:11686325-Thromboplastin
pubmed:year
2001
pubmed:articleTitle
Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity.
pubmed:affiliation
DuPont Pharmaceuticals Company, Wilmington, DE 19880-0400, USA. ira.b.dicker@dupontpharma.com
pubmed:publicationType
Journal Article